Ethical and Regulatory Considerations of AI in Drug Discovery The adoption of AI in drug discovery raises important ethical and regulatory questions. Transparency, accountability, and fairness are key considerations. Regulators require explainable AI models to ensure decisions are scientifically sound. Developers must also address data bias to avoid inequitable outcomes. Strong governance frameworks and collaboration between stakeholders are essential for responsible AI use. Ethical AI practices will build trust and support sustainable innovation. ➤➤➤ Reference - https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393